WELL Health Technologies Corp, 375 Water Street Suite 550, Vancouver, BC (2026)

12/19/2025

🎁 WELL Gives Back! ❤️

Sharing a few photos from our recent volunteering initiative! A group of team members from WELL HQ and our BC clinic teams spent time with CityReach Care Society , wrapping gifts and preparing festive packages for their annual Boxes of Love event — an initiative that brings Christmas joy and support to vulnerable families across the Greater Vancouver area.

These gifts will be given to over 2,000 children and families, helping make the season a little brighter through thoughtful presents, treats, and essentials. We’re proud to support our community and contribute alongside CityReach in spreading hope and holiday cheer. 🎄✨

Thank you to everyone who volunteered! Your time and heart truly make a difference! 💛

12/08/2025

WELL a digital healthcare company focused on improving health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its majority-owned subsidiary WELLSTAR Technologies Corp. (“WELLSTAR”) has completed its previously announced Series B Preferred Share financing (the “Series B Financing”), raising aggregate gross proceeds of approximately $62 million.

📌 WELLSTAR announces it has closed on a $62 million equity placement supported by Mawer Investment Management, Edgepoint Wealth Management, PICTON Investments and the management team of WELL and WELLSTAR to fund its pre-spinout growth objectives.

📌 WELLSTAR is a high growth, profitable, pure-play SaaS healthcare technology company serving over 40% of providers across Canada with high quality technology and services that significantly improve patient care.

https://ow.ly/hnLW50XFLgC

12/08/2025

WELL a digital healthcare company focused on improving health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its majority-owned subsidiary WELLSTAR Technologies Corp. (“WELLSTAR”) has completed its previously announced Series B Preferred Share financing (the “Series B Financing”), raising aggregate gross proceeds of approximately $62 million.

📌 WELLSTAR announces it has closed on a $62 million equity placement supported by Mawer Investment Management, Edgepoint Wealth Management, PICTON Investments and the management team of WELL and WELLSTAR to fund its pre-spinout growth objectives.

📌 WELLSTAR is a high growth, profitable, pure-play SaaS healthcare technology company serving over 40% of providers across Canada with high quality technology and services that significantly improve patient care.

To learn more, please follow the link below. 🔗
https://ow.ly/Ye8850XFLnV

11/24/2025

This November, we were honoured to participate in the Infoway Partnership Conference 2025 alongside Wellstar, OceanMD, and HealWell AI. Amir Javidan, Chief Executive Officer of WELLSTAR, delivered the opening remarks ahead of the day one closing keynote and joined a panel discussion - valuable opportunities to engage with the public sector community on connected care, interoperability, and positively impacting healthcare outcomes across Canada.

Thank you to the Infoway for the thoughtful dialogue and the value this gathering brings yearly! 🚀

11/20/2025

WELL is pleased to announce continued momentum across its Canadian Patient Services business driven by strong organic growth, meaningful improvements in clinic digitization, and successful ex*****on on its primary care patient opening initiative. Please see key highlights below.

📌 WELL is pleased to provide enhanced disclosure on its organic growth metrics, including detailed breakdowns of same-clinic growth and absorption-driven organic growth.

📌 Overall same clinic revenue growth across WELL Medical Centres (“WMC”) and WELL Diagnostics Centres (“WDC”) was 10% and 16% YoY respectively.

📌 WELL disclosed that it has achieved 92% digitization for all primary care clinics that have been in its network for longer than 9 months.

📌 On June 24, 2025, WELL announced that it had created availability for over 45,000 new primary care patient openings across 3 provinces enabled by investments in physician recruitment and digital transformation. WELL is pleased to report that as of October 31, 2025, it had already filled 25,000 of these new openings and expects to fully satisfy the balance by end of Q1.

To learn more, please follow the link below. 🔗

https://ow.ly/CKx750XuRZz

11/13/2025

WELL is pleased to provide a corporate update on its majority-owned platform subsidiary, Wellstar, including recent developments related to OceanMD's eReferral platform, recent strategic acquisitions, and the completion of a $62 million Series B financing round. Please see key highlights below.

📌 WELLSTAR's OceanMD has been awarded a material eReferral contract with a Canadian province following a competitive procurement process.

📌 WELLSTAR’s OceanMD is Canada’s eReferral market leader with programs in four Canadian provinces now facilitating over 1.7 million eReferrals annually nationwide with participation from more than 20,000 physicians and 3,800 clinics.

📌 WELLSTAR has signed three M&A-related transactions in November, including leading-edge Ambient AI Scribe Mutuo and two others within the Company’s billing unit.

📌 WELLSTAR recently released its Q3 financials, which demonstrated accelerated organic growth of 26% with overall YoY revenue growth of 67%.

📌 On October 31, 2025, WELLSTAR announced that it had executed an agreement with a leading group of institutional investors to raise $62 million to execute on growth opportunities. WELLSTAR has added a new member to its corporate development team and is aggressively pursuing its M&A pipeline.

To learn more, please follow the link below. 🔗

https://ow.ly/YHhw50Xrh89

11/10/2025

We’re excited to share that Eva Fong, Chief Financial Officer at WELL Health, has been named a C-Suite Awards winner by Business in Vancouver. This honour is a reflection of Eva’s dedication and work ethic!

The BIV feature on Eva highlighted her outstanding career accomplishment, having overseen more than 100 mergers and acquisitions, sometimes at the rate of one per month. Her leadership has been essential to WELL’s growth, leading the company from about $2 million in early revenue to over $1 billion in annual run rate today.

Congratulations to Eva for her remarkable achievement, impact on WELL, and the healthcare industry. Read the full article below. 🚀

https://ow.ly/Xu0650XpIXy

11/06/2025

WELL is pleased to announce its interim consolidated financial results for the quarter ended September 30, 2025. Please see key highlights below.

📌 WELL achieved record quarterly revenues of $364.6 million in Q3-2025, an increase of 56% compared to Q3-2024.

📌 WELL achieved record Adjusted EBITDA of $59.9 million in Q3-2025, an increase of 296% compared to $15.1 million in Q3-2024.

📌 Canadian Patient Services revenue and Adjusted EBITDA was $110.1 million and $14.1 million respectively in Q3-2025, an increase of 41% and 47%.

📌 WELL’s majority owned subsidiary, WELLSTAR Technologies Corp. announced a financing for $62 million at a 50% increase in share price relative to its prior December 2024 financing.

📌 WELL reaffirms its previously provided guidance for annual revenue between $1.40 billion to $1.45 billion with Adjusted EBITDA between $190 million to $210 million.

Hamed Shahbazi, Chairman and CEO of WELL commented, “We had an excellent quarter driven by strong performance network–wide but especially in our core Canadian businesses. We’re seeing our technology enabled approach, which is increasingly AI–enabled, drive real business results across the enterprise."

To read the full news release, follow the link below.

https://ow.ly/PWFq50XnJ8X

11/03/2025

We are proud to announce that Hamed Shahbazi, Founder, Chairman, and CEO of WELL Health, has been named TSX Technology Executive of the Year at the 2024–2025 Cantech Letter Awards, held during the 2025 Cantech Investment Conference in Toronto on October 9.

This award celebrates Hamed's visionary leadership in Canadian healthcare and recognizes the commitment of both the larger WELL Health team and the Providers who provide patient care every day.

Learn more at the link below!

https://ow.ly/u6h350XlZvv

10/31/2025

WELL is pleased to announce its majority-owned subsidiary Wellstar has entered into agreements to complete a Series B preferred share investment in the aggregate amount of approximately C$62 million at an offering price of C$1.50 per Series B Share. Please read the key highlights below.

📌 WELLSTAR enters into subscription agreements to complete a C$62 million equity placement supported by Mawer Investment Management, Edgepoint Wealth Managemen, PICTON Investments and the management team of WELL and WELLSTAR to fund its pre-spinout growth objectives.

📌 The financing is anticipated to close early December, subject to certain closing conditions.

📌 WELLSTAR is a high growth, profitable, pure-play SaaS healthcare technology company serving over 40,000 providers across Canada with high quality technology and services that significantly improve patient care.

To learn more details, follow the link below. 🔗

https://ow.ly/w3pT50Xl60K

10/23/2025

WELL will release Fiscal Third Quarter 2025 results before the market opens on Thursday, November 6, 2025. A conference call and webcast will follow at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time), hosted by Hamed Shahbazi, Chairman and Chief Executive Officer, and Eva Fong, Chief Financial Officer. We welcome everyone to join us!

Follow the link below for webcast details.

https://ow.ly/UkQk50Xh323

10/03/2025

Cantech Letter has published a feature article based on a research note by Stifel analyst Justin Keywood that suggests investors revisit WELL Health (TSX: WELL) as a result of recent transactions and the early consolidation trend of Canadian healthcare assets.

The article suggests that WELL may be undervalued as Stifel maintains its “Buy” rating with a $9 target price, noting the company's strong growth strategy through clinic acquisitions and digital transformation. The article further highlights upcoming catalysts, including continued M&A of Canadian clinics, margin expansion, and the potential spin-out of its Wellstar digital SaaS platform.

Read the full article below.

https://ow.ly/yFzW50X5WKU

WELL Health Technologies Corp

12/19/2025

12/08/2025

12/08/2025

11/24/2025

11/20/2025

11/13/2025

11/10/2025

11/06/2025

11/03/2025

10/31/2025

10/23/2025

10/03/2025

Address

Website

Alerts

Shortcuts

Share

Category